Identification of an Immune-Related Gene Signature Associated with Prognosis and Tumor Microenvironment in Esophageal Cancer

Figure 10

Therapeutic sensitivity analyses. TIDE results revealed differences in CD8⁺ T cell scores (a), CAF scores (b), T cell exclusion scores (c), and TIDE scores (d) between the two groups. High-risk patients sustained a better response to docetaxel (e), doxorubicin (f), gemcitabine (g), imatinib (h), and sorafenib (i). Low-risk patients experienced better responses to roscovitine (j), lenalidomide (k), and rapamycin (l). ; ; .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)